Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor

被引:49
|
作者
Esch, JSA
Cruz, MA
Siegel, JB
Anrather, J
Robson, SC
机构
[1] HARVARD UNIV,SCH MED,DEPT MED,BETH ISRAEL DEACONESS MED CTR,BOSTON,MA
[2] HARVARD UNIV,SCH MED,DEPT SURG,BETH ISRAEL DEACONESS MED CTR,BOSTON,MA 02115
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT HEMATOL & ONCOL,BOSTON,MA 02115
关键词
D O I
10.1182/blood.V90.11.4425.4425_4425_4437
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet activation and microthrombus formation are invariable features of xenograft rejection and the vascular injury observed when porcine organs are transplanted into primates. This pathological process could be mediated, at least in part, by aberrant interactions of von Willebrand Factor (vWF) associated with the donor vasculature with host platelets, Unlike human vWF, native porcine vWF (pvWF) interacts with human GPlb independently of shear stress or nonphysiological stimuli, eg, ristocetin. We therefore contrasted the potential of isolated human and porcine vWF-A(1)-domains to interact with human platelets in vitro. Both human and porcine vWF-A(1)-domains expressed as glycosyl phosphatidylinositol-linked FLAG fusion proteins on COS-7 cells induced GPlb-dependent aggregation and intracellular Ca++ uptake of platelets, independent of both the remainder of the vWF protein and additional modifying factors. Porcine A(1)-domains were more potent than human homologues, and in addition ristocetin could boost platelet aggregation only with the human A(1)-domain, Putative conformational changes in the porcine A(1)-domain could result in the heightened, ristocetin-independent interactions observed with human platelets and may be of importance for xenograft survival. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:4425 / 4437
页数:13
相关论文
共 50 条
  • [1] Activation of protein-tyrosine kinase pathways in human platelets stimulated with the A1 domain of von Willebrand factor
    Satoh, K
    Asazuma, N
    Yatomi, Y
    Fujimura, Y
    Miura, S
    Titani, K
    Ozaki, Y
    PLATELETS, 2000, 11 (03) : 171 - 176
  • [2] Platelet aggregation by membrane-expressed A1 domains of von Willebrand Factor is dependent on residues Asp 560 and Gly 561
    Esch, JSA
    Robson, SC
    Cruz, MA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (04) : 873 - 877
  • [3] Differential surface activation of the A1 domain of von Willebrand factor
    Tronic, Elaine H.
    Yakovenko, Olga
    Weidner, Tobias
    Baio, Joe E.
    Penkala, Rebecca
    Castner, David G.
    Thomas, Wendy E.
    BIOINTERPHASES, 2016, 11 (02)
  • [4] Activation of A1 Domain Adhesiveness in von Willebrand Factor by Elongational Force
    Springer, Timothy A.
    Kim, Jongseong
    BLOOD, 2012, 120 (21)
  • [5] Mechanical Regulation of Von Willebrand Factor A1 Domain
    Thomas, Wendy E.
    Penkala, Becky
    Whitfield, Matthew
    An-Yue Tu
    Munday, Adam
    Kulman, John
    Lopez, Jose A.
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 480 - 481
  • [6] Ligand Complexes of von Willebrand Factor Domain A1
    Hooley, Elizabeth
    Emsley, Jonas
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2006, 62 : S173 - S173
  • [7] von Willebrand factor A1 domain: stuck in the middle
    Lenting, P. J.
    Denis, C. V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) : 1361 - 1362
  • [8] Structure and function of the von Willebrand factor A1 domain
    Varughese, KI
    Celikel, R
    Ruggeri, ZM
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2002, 3 (03) : 301 - 312
  • [9] Binding of the von Willebrand Factor A1 domain to histone
    Ward, CM
    Tetaz, TJ
    Andrews, RK
    Berndt, MC
    THROMBOSIS RESEARCH, 1997, 86 (06) : 469 - 477
  • [10] Misfolding of the von Willebrand factor A1 domain in Type 2 von Willebrand disease
    Auton, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 90 - 90